Company profile: Accriva Diagnostics
1.1 - Company Overview
Company description
- Provider of near patient testing systems and advanced diagnostic solutions, offering compact and high sensitivity immunoassay analyzers, hematology analyzers, and clinical chemistry analyzers. Founded in 2009 and based in San Diego, California.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Accriva Diagnostics
Endovascular Engineering
HQ: United States
Website
- Description: Provider of preclinical mechanical thrombectomy solutions, including the Hēlo™ G1 Thrombectomy System for non-surgical removal of thrombi and emboli from venous vasculature. Features include a self-expanding funnel with wide distal opening for large bore clot engagement, dual-action high-speed agitation with physician-controlled aspiration, and a single-pass catheter with integrated handle for navigating complex anatomies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endovascular Engineering company profile →
CellaVision
HQ: Sweden
Website
- Description: Provider of digital hematology microscopy solutions, including analyzers, instruments, reagents, and software, that automate and simplify routine analysis of blood and other body fluids and support hematology laboratory differentials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CellaVision company profile →
Drew Scientific
HQ: United States
Website
- Description: Provider of analytical instruments and reagents worldwide, including cell counters for clinical hematology, cell counters for veterinary hematology and research, hemoglobin analyzers for diabetes (HbA1c), and related reagents and controls.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Drew Scientific company profile →
Disc Medicine
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for hematologic diseases and rare blood disorders, including Bitopertin, an oral GlyT1 inhibitor for erythropoietic porphyrias and abnormal erythropoiesis; DISC-0974, an injectable monoclonal antibody targeting hemojuvelin (HJV) to suppress hepcidin for anemias of inflammation; and DISC-3405, an injectable monoclonal antibody inhibiting TMPRSS6 to increase hepcidin for polycythemia vera and iron overload.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Disc Medicine company profile →
Hemcheck
HQ: Sweden
Website
- Description: Provider of point-of-sampling products that identify non-analyzed blood samples by detecting hemolysis (broken red blood cells), the most common cause of sample non-analysis. Helge detects hemolysed blood samples, addressing issues that lead to poorer care, patient risk, and high societal costs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemcheck company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Accriva Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Accriva Diagnostics
2.2 - Growth funds investing in similar companies to Accriva Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Accriva Diagnostics
4.2 - Public trading comparable groups for Accriva Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →